A network map of GDNF/RET signaling pathway in physiological and pathological conditions-Reference-Cited by-同舟云学术

A network map of GDNF/RET signaling pathway in physiological and pathological conditions

Published:2023-01-30 Issue:3 Volume:17 Page:1089-1095
ISSN:1873-9601
Container-title:Journal of Cell Communication and Signaling
language:en
Short-container-title:J. Cell Commun. Signal.

Author:

Mol Praseeda^ORCID,Balaya Rex Devasahayam Arokia^ORCID,Dagamajalu Shobha^ORCID,Babu Sreeranjini,Chandrasekaran Pavithra,Raghavan Reshma,Suresh Sneha,Ravishankara Namitha,Raju Anu Hemalatha,Nair Bipin,Modi Prashant Kumar,Mahadevan Anita^ORCID,Prasad Thottethodi Subrahmanya Keshava^ORCID,Raju Rajesh^ORCID

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s12079-023-00726-1.pdf

Reference51 articles.

1. Adashek JJ, Desai AP, Andreev-Drakhlin AY, Roszik J, Cote GJ, Subbiah V (2021) Hallmarks of RET and Co-occuring genomic alterations in RET-aberrant cancers. Mol Cancer Ther 20(10):1769–1776

2. Airaksinen MS, Titievsky A, Saarma M (1999) GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13(5):313–325

3. Bespalov MM, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhaes AC, Kulesskiy E, Paveliev M, Rivera C, Rauvala H, Saarma M (2011) Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J Cell Biol 192(1):153–169

4. Besset V, Scott RP, Ibanez CF (2000) Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J Biol Chem 275(50):39159–39166

5. Boulay A, Breuleux M, Stephan C, Fux C, Brisken C, Fiche M, Wartmann M, Stumm M, Lane HA, Hynes NE (2008) The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer Res 68(10):3743–3751

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review);Bulletin of Experimental Biology and Medicine;2024-09-12

2. Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson’s disease model;Frontiers in Bioengineering and Biotechnology;2024-08-08

3. The future neurotrophic factor therapy in Parkinson's disease;International Review of Movement Disorders;2024